EPITRANSCRIPTOMIC ANALYSIS OF GLIOMA

The present disclosure relates to the field of epitranscriptomic signatures to determine glioma progression versus glioma pseudoprogression. Further, wherein identifying whether a subject has a progressive glioma or a pseudoprogressive glioma, the method comprising: a. isolating a tissue biopsy from...

Full description

Saved in:
Bibliographic Details
Main Authors OTERO, Jose, GIGLIO, Pierre, WANG, Wesley
Format Patent
LanguageEnglish
French
Published 18.04.2024
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to the field of epitranscriptomic signatures to determine glioma progression versus glioma pseudoprogression. Further, wherein identifying whether a subject has a progressive glioma or a pseudoprogressive glioma, the method comprising: a. isolating a tissue biopsy from the subject; b. detecting an altered N6-Methyladenosine (m6A) epigenetic modification on an mRNA from the tissue biopsy is disclosed. La présente divulgation concerne le domaine des signatures épitranscriptomiques pour déterminer la progression d'un gliome par rapport à une pseudo-progression de gliome.
Bibliography:Application Number: WO2023US30443